Eris Lifesciences Limited

NSE ERIS.NS

Eris Lifesciences Limited Dividend Per Share for the year ending March 31, 2024: USD -0.00

Eris Lifesciences Limited Dividend Per Share is USD -0.00 for the year ending March 31, 2024, a -100.00% change year over year. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.

Eris Lifesciences Limited Dividend Per Share for the year ending March 31, 2023 was USD 0.09, a 13.00% change year over year.
Eris Lifesciences Limited Dividend Per Share for the year ending March 31, 2022 was USD 0.08, a 5.33% change year over year.
Eris Lifesciences Limited Dividend Per Share for the year ending March 31, 2021 was USD 0.08, a 65.29% change year over year.
Eris Lifesciences Limited Dividend Per Share for the year ending March 31, 2020 was USD 0.05, a 0.00% change year over year.

Key data

Date	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)

NSE: ERIS.NS

Eris Lifesciences Limited

CEO	Mr. Amit Indubhushan Bakshi
IPO Date	June 30, 2017
Location	India
Headquarters	Shivarth Ambit
Employees	3,620
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies Eyewear Personal Care

Description

Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, antidiabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.

Key trends

Past 5 years